Filter Results:
(5,075)
Show Results For
- All HBS Web
(5,075)
- People (18)
- News (1,638)
- Research (2,726)
- Events (5)
- Multimedia (109)
- Faculty Publications (1,740)
Show Results For
- All HBS Web
(5,075)
- People (18)
- News (1,638)
- Research (2,726)
- Events (5)
- Multimedia (109)
- Faculty Publications (1,740)
- June 2020
- Article
Overcoming Barriers to Early Disease Intervention
By: H. Hugo Caicedo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland and Gary P. Pisano
It is widely acknowledged that earlier intervention in many disease processes leads to better patient outcomes and lower treatment costs. To date, most efforts at early disease intervention have focused on "primary prevention" which focuses on preventing diseases in... View Details
Caicedo, H. Hugo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland, and Gary P. Pisano. "Overcoming Barriers to Early Disease Intervention." Nature Biotechnology 38, no. 6 (June 2020).
- 03 Jan 2011
- Research & Ideas
Most Popular Articles of 2010
doctoral student Julia Adler-Milstein, Harvard School of Public Health professor Sara Singer, and HBS professor Michael W. Toffel examine this question in a hospital setting. Conceptual Foundations of the... View Details
Keywords: by Staff
- 2023
- Working Paper
Are Hospital Quality Indicators Causal?
By: Amitabh Chandra, Maurice Dalton and Douglas O. Staiger
Hospitals play a key role in patient outcomes and spending, but efforts to improve their quality are hindered because we do not know whether hospital quality indicators are causal or biased. We evaluate the validity of commonly used quality indicators, such as... View Details
Keywords: Quality; Health Care and Treatment; Measurement and Metrics; Outcome or Result; Health Industry
Chandra, Amitabh, Maurice Dalton, and Douglas O. Staiger. "Are Hospital Quality Indicators Causal?" NBER Working Paper Series, No. 31789, October 2023.
- 01 Sep 2004
- News
A Market-Based Prescription
for her innovative research and teaching on the business of health care, Herzlinger has long predicted the unraveling of managed care in the United States, along with the rise... View Details
- 25 Aug 2014
- News
The First Five Years: Raymond Hwang (MBA 2010)
were exposed to at HBS can be applied to problems in health care and medicine. As an industry, we face the same fundamental challenges, just with the addition of some special... View Details
- November 2005 (Revised November 2005)
- Case
Massachusetts General Hospital and the Enbrel Royalty
By: David S. Scharfstein and Darren R. Smart
Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well... View Details
Keywords: Valuation; Price; Investment Return; Capital; Value; Revenue; Health Care and Treatment; Health Industry; Health Industry; Massachusetts
Scharfstein, David S., and Darren R. Smart. "Massachusetts General Hospital and the Enbrel Royalty." Harvard Business School Case 206-075, November 2005. (Revised November 2005.)
- 26 Sep 2019
- News
Trying to shop for medical care? Lots of luck with that
- 04 Aug 2009
- First Look
First Look: August 4
709-474 In 2005, Partners in Health (PIH) was invited by the Rwandan Ministry of Health to assume responsibility for the management of public... View Details
Keywords: Martha Lagace
- 22 Jan 2018
- News
The First Five Years: ‘30 Under 30’ Edition
joked that after our weekly two-hour class with Professor Ghosh, we felt like we had gone to church and confession for the week.” Guram:“Regina Herzlinger. Her belief in the power of entrepreneurship and View Details
- 14 Jul 2020
- Research & Ideas
Restarting Under Uncertainty: Managerial Experiences from Around the World
Health Organization recommendations when the crisis was still far away. The protocols were ready within two weeks. By mid-March, the implementation was monitored on a daily basis by a crisis committee. Key learnings We can derive three... View Details
- October 2005 (Revised September 2006)
- Case
DentalCorp
By: Richard G. Hamermesh and Ricardo Reisen de Pinho
DentalCorp is the fifth largest provider of dental insurance in Brazil and has tripled its sales in the past two years. Whether to expand to Chile or to continue expansion in Brazil is the major strategic choice facing the company at the end of 2004. View Details
Keywords: International Finance; Expansion; Entrepreneurship; Health Care and Treatment; Global Strategy; Health Industry; Health Industry; Brazil; Chile
Hamermesh, Richard G., and Ricardo Reisen de Pinho. "DentalCorp." Harvard Business School Case 806-023, October 2005. (Revised September 2006.)
- 23 Jan 2012
- Research & Ideas
Break Your Addiction to Service Heroes
that there are a lot of heroic people in service organizations who feel compelled to be the best at everything. That's particularly evident in mission-driven and health View Details
- 28 May 2019
- News
Cure All
How would you advise them? Leemore Dafny: What I’d say is something that holds true in most health care service markets View Details
- 02 Nov 2017
- News
Could a Hackathon Help Solve the Heroin Crisis?
- October 2012 (Revised October 2016)
- Case
Predilytics
By: Robert F. Higgins and Annelena Lobb
The management team at Predilytics, a healthcare analytics firm, must decide whether to accept a Series A venture capital financing deal. The company provided analytic services to healthcare plans, typically Medicare Advantage plans, in efforts to draw conclusions from... View Details
Keywords: Analytics; Healthcare; Medicare; Health Care and Treatment; Mathematical Methods; Health Industry; New England; United States
Higgins, Robert F., and Annelena Lobb. "Predilytics." Harvard Business School Case 813-023, October 2012. (Revised October 2016.)
- 08 Sep 2013
- News
Management lessons are just what the doctor ordered
- 01 Dec 2018
- News
Collaborative Cures
as well as additional funding for activities such as due diligence, market research, and other tasks necessary to determine the best route for product commercialization. Since its launch in 2013, fellows... View Details
- 20 Jun 2017
- First Look
First Look at New Research and Ideas, June 20
School Case 317-103 PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World PharmAccess is an Amsterdam-based NGO working to support the development of the private health... View Details
Keywords: Sean Silverthorne